Fierce Pharma is launching the weekly Oral GLP-1 Tracker, leveraging analysts’ notes and IQVIA data to monitor prescription trends and shifting market shares as Novo Nordisk's Wegovy pill and Eli Lilly's Foundayo vie to become the go-to oral weight-loss solution for millions.
China is now a peer competitor in drug innovation — and it intends to stay that way on its own terms, writes Dennis Kwok.
اضطراب الإخراج ليس مجرد إزعاج عابر، بل حالة ترتبط غالبًا بتغير قوام الفضلات وصعوبة مرورها داخل الأمعاء، ما يسبب شعورًا بعدم الراحة وقد يمتد تأثيره إلى …
President Trump arrived at his Doral golf resort on Sunday, as the PGA Tour returned to the venue for the first time since 2016. The president …
He didn’t just shout me a drink, he made me feel understood and seen. I’ve never forgotten his gestureI had picked up a box of books …